Zein Obagi, M.D., Receives JDD Leaders of Distinction Award
IRVINE, Calif., Jan. 21, 2014 /PRNewswire/ -- ZO Skin Health, Inc. is especially pleased to announce that internationally renowned dermatologist Zein Obagi, M.D., is a recipient of the prestigious Journal of Drugs in Dermatology (JDD) Leaders of Distinction Award.
Dr. Obagi was nominated by his peers for his excellence in acne treatment and care and thus recognized as a Leader of Distinction in the field of Acne.
"I'm honored to be selected as a distinguished leader in acne care by such an esteemed panel of physicians," says Dr. Obagi.
"We commend Dr. Obagi as he earns this well deserved recognition," said James R. Headley, CEO and President of ZO Skin Health, Inc. "His therapeutic innovations in skin health continue to move the industry forward."
As the Medical Director of ZO Skin Health, Inc., and the Obagi Skin Health Institute, Dr. Obagi has redefined the science of skincare for over 30 years. With his unique approach aimed at achieving and maintaining healthy skin, Dr. Zein Obagi is widely respected as a key innovator in the field of acne prevention. His groundbreaking protocols, products and educational programs have indelibly influenced the skincare industry, allowing for higher success rates and greater patient satisfaction with oil control and acne care.
About ZO Skin Health, Inc.
ZO Skin Health, Inc. develops and delivers innovative skincare solutions that optimize skin health around the globe. Utilizing cutting-edge science and Dr. Zein Obagi's extensive clinical experience creating treatments and regimens for healthy skin, ZO Skin Health, Inc. provides comprehensive skincare programs for physicians and their patients. Committed to advancing effective treatments for healthy skin, ZO Skin Health, Inc. supports physicians' practices through skin health seminars and clinical training, and patients through a variety of educational programs. As a result, ZO Skin Health, Inc. is focused on providing products and protocols that bridge the gap between therapeutic treatments and daily care that allow patients to experience continuously healthy skin regardless of their age or unique skin condition. For more information, visit www.zoskinhealth.com.
About Zein Obagi, M.D.
Researcher, innovator, scientist, published author, lecturer and board-certified dermatologist, Dr. Zein Obagi has achieved international renown as a leading authority on skin rejuvenation. He is the ZO Skin Health, Inc. founder and medical director and is responsible for the development of new skincare treatments, protocols and products to achieve healthy skin.
Over twenty years ago, Dr. Zein Obagi pioneered the concept of skin health and conceived of, and brought to market, a line of medical skincare products – the original Obagi Nu-Derm® System – that transformed aging skin. Dr. Obagi founded WorldWide Products, which produced and marketed the original Obagi Nu-Derm® System. At that time, Dr. Obagi merely intended to challenge the norms of traditional skin care. Instead he shattered the status quo. Today his ideas about skin health are no longer surprising; they have become mainstream. Subsequently WorldWide was purchased by Obagi Medical Products, Inc., a company with which Dr. Obagi no longer has any affiliation, but which retained his family name (Obagi®) as their trademark.
ZO Skin Health, Inc. and Dr. Obagi have no business relationship with Obagi Medical Products, and Obagi Medical Products does not sell or endorse using any ZO® product. "ZO" is a registered trademark of ZO Skin Health, Inc. "Obagi" and "Obagi Nu-Derm" are registered trademarks of Obagi Medical Products, Inc.
About the JDD
The Journal of Drugs in Dermatology (JDD) is a full-color, peer-reviewed publication founded by the renowned Dr. Perry Robins, MD. Now in it's 11th year, it offers one of the fastest routes to disseminate dermatologic information, and is considered the fastest growing publication in dermatology.
JDD reaches around 14,500 dermatology healthcare professionals and has been recognized as the official publication of the International Society of Dermatologic Surgery (ISDS) and the Orlando Dermatology Aesthetic and Clinical (ODAC) Conference. To educate physicians, optimize patient outcomes, and disseminate key scientific information.
SOURCE ZO Skin Health, Inc.